SUPX:NASDAQSuperX AI Technology Limited Analysis
Data as of 2026-06-14 - not real-time
$8.23
Latest Price
8/10Risk
Risk Level: High
Executive Summary
SuperX AI Technology Limited trades at $8.23, well above its DCF fair value of $4.45, indicating significant overvaluation. The price sits below the 20‑day SMA (10.01) and the 50‑day SMA (8.93), and far under the 200‑day SMA (26.05), while the MACD histogram is negative and the RSI sits at 44, suggesting neutral momentum but a bearish technical bias. Revenue growth is strong at 130% YoY, yet the company posts a negative operating margin of –2.0% and zero earnings per share, with a high price‑to‑book ratio of 9.2. Volatility is extreme at 155% over the past 30 days and beta exceeds 1.5, underscoring heightened market risk. Despite the growth narrative, the combination of weak profitability, high valuation multiples, and aggressive price swings makes the stock a risky short‑term play.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below short‑term SMAs
- Bearish MACD signal
- Extreme short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Overvaluation relative to DCF
- Negative operating margins
- High beta and sector exposure
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Strong revenue growth in AI infrastructure
- Potential for margin improvement
- Long‑term demand for AI compute solutions
Key Metrics & Analysis
Financial Health
Revenue Growth130.40%
ROE-158.36%
ROA-25.03%
Debt/Equity8.87
P/B Ratio9.2
Op. Cash Flow$-8334584
Free Cash Flow$4.9M
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI44.3
Support$8.03
Resistance$12.48
MA 20$10.01
MA 50$8.93
MA 200$26.05
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value$4.45
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.58
Volatility155.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.